BioSpace News Archive

NuProbe Global announced today the formation of its Scientific Advisory Board (SAB) with genomics pioneers George M. Church, Ph.D. and David R. Walt, Ph.D.

Seoul National University Hospital (SNUH) recently announced that it has successfully implemented the interface of the clinical and genomic data in accordance with the Korean medical system and officially launched the Syapse Precision Medicine (PM) platform for the first time in both Korea and APAC.

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ACADIA Pharmaceuticals Inc. (“Acadia” or the “Company”) (NASDAQ: ACAD) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Acadia securities between April 29, 2016 and July 9, 2018

Real Time Medical is pleased to announce a new AI training, research and validation service to aid AI application development for healthcare as part of a collaboration between MIIRCAM (Medical Imagining Informatics Research Centre at McMaster), Hamilton Health Sciences and Real Time Medical.

US Medical Innovations, LLC announced that the United States Patent Office (USPO) has issued USPI patent No. 10,023,858 B2, further expanding its intellectual patent property portfolio for the application of delivering Cold Atmospheric Plasma (CAP) technology to selectively target cancer cells.

The momentum for “single payer,” “Medicare for All,” or “Medicare Extra” is building at both the state and national levels, especially after the narrow primary election victory of young democratic socialist Alexandra Ocasio-Cortez in New York, observes the Association of American Physicians and Surgeons (AAPS).

Personal Genome Diagnostics Inc. today announced that PGDx elio™ plasma resolve has received Breakthrough Device designation from The Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA).

An elevation from a Level II accreditation level to a Level I accreditation level has been granted to one hospital in Pennsylvania starting September 1, 2018.

Slayback Pharma LLC (“Slayback”), a privately held pharmaceutical research and development company, announced today the appointment of Dr Girish Jain as Senior Vice President and Head of Global R&D. Dr Jain will be based out of Slayback’s Hyderabad, India office.

Petrichor Healthcare Capital Management today announced the appointment of Raymond F. Schinazi, PhD, DSc (Hon) to its Advisory Board.